ISOVAC designs, develops, commercializes, and currently manufactures products that provide Chemical / Biological / Radiological isolation and containment of casualties and remains to protect personnel, equipment, and transport assets. These products are designed to mitigate the effects of CBRN warfare, terrorist attacks, naturally occurring disease outbreaks and pandemics (e.g., COVID-19, H5N1, SARS, Ebola, etc.)
ISOVAC shared an update into its activities in the patient isolation unit marketplace, which has served to underline the importance of proactive preparedness by governments and healthcare service providers around…
ISOVAC patient isolation units allow safe transport of infectious patients
AirMed&Rescue spoke to ISOVAC President Pete Jenkner and VP Chris Schultz to find out more about how the company is developing innovative new products to meet the needs of international…
